Due to the overexpression of MUC1 by almost all epithelial carcinomas, glycopeptide partial sequences with abnormal O-glycans contained in the MUC1’s tandem repeats are ideal potential antigens and biomarkers that could be detected by monoclonal antibodies. The gene discussed is MUC1; the disease is carcinoma.